✉news ScienceBiology first seen 12 h ago, last 6 h ago, peak #7
ARDD 2026 Set to Convene AI and Pharma Leaders on Longevity at Harvard
Original: ARDD 2026 Signals a New Era for Longevity Biotechnology as Frontier AI, Big Pharma, and Scientific Pioneers Converge at Harvard
ARDD 2026, the flagship longevity science meeting, is being billed as a turning point for aging biotechnology, bringing together frontier AI companies, major pharmaceutical firms and leading researchers at Harvard. Organisers say the convergence reflects growing industry investment in therapies targeting aging itself. Insilico Medicine, an AI drug discovery company, is among those promoting the event.
Why now: Announcement of a major longevity conference drawing AI and pharmaceutical players has drawn attention from the biotech and aging research community.
ARDD 2026Harvard UniversityInsilico Medicine
Rank over time, top of the chart is #1. 6 snapshots from 12 h ago to 6 h ago.
Evidence
- ARDD 2026 Signals a New Era for Longevity Biotechnology as Frontier AI, Big Pharma, and Scientific Pioneers Converge at Harvard · Insilico Medicine
API: https://socialmediatrends-api.osmike.com/v1/trends/1963220